Rite Aid Corporation (NYSE:RAD) today announced sales results for December.
For the four weeks ended Dec. 28, 2013, same store sales increased 2.9 percent over the prior-year period. December front-end same store sales increased 1.0 percent. Pharmacy same store sales, which included an approximate 102 basis points negative impact from new generic introductions, increased 4.1 percent. Prescription count at comparable stores decreased 2.0 percent over the prior-year period, driven by a decrease in flu-related prescriptions and flu shots.
Total drugstore sales for the four-week period increased 2.7 percent to $2.109 billion compared to $2.054 billion for the same period last year. Prescription sales accounted for 63.6 percent of drugstore sales, and third party prescription sales represented 97.2 percent of pharmacy sales.
Same store sales for the 43-week period ended Dec. 28, 2013 increased 0.5 percent over the prior-year period. Front-end same store sales increased 0.1 percent over the prior-year period while pharmacy same store sales increased 0.7 percent. Prescription count at comparable stores was flat compared to the prior-year period.
Total drugstore sales for the 43 weeks ended Dec. 28, 2013 increased 0.2 percent with sales of $20.953 billion compared to $20.913 billion for the same period last year. Prescription sales represented 67.5 percent of total drugstore sales, and third party prescription sales represented 97.1 percent of pharmacy sales.
Rite Aid is one of the nation’s largest drugstore chains. On Dec. 28, 2013, the company operated 4,592 stores compared to 4,630 stores in the like period a year ago. Information about Rite Aid, including corporate background and press releases, is available through the company’s website at http://www.riteaid.com. Note that all sales data in this release is preliminary, unaudited and subject to revision.
Statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties that are described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K and in other documents that we file or furnish with the Securities and Exchange Commission, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Rite Aid expressly disclaims any current intention to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
|Rite Aid Reports Same Store Sales for August ()|
|Rite Aid Reports Same Store Sales for November ()|
|Rite Aid Reports Same Store Sales for February (2014/3/6)|
|Rite Aid Reports Same Store Sales for July ()|
|Rite Aid Reports Same Store Sales for September (2013/10/3)|
|Rite Aid Reports Same Store Sales for October ()|
|Rite Aid Reports Same Store Sales for January (2014/1/30)|
|Rite Aid Reports Same Store Sales for March (2014/4/3)|
|J.C. Penney reports same-store sales growth (2014/2/4)|
|Rite Aid Same-Store Sales Rise in February, 4th Quarter ()|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.